Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Septerna, Inc.SEPN · Entity 2452 | SVP, Biological Sciences | February 06, 2026 | February 10, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Septerna, Inc.
Report date February 06, 2026 · Filed February 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $25.41 · Expires 2036-02-05 | Direct | 80,000 |
Reported balance
After 2026-02-06 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-02-06 · Grant · Acquired 80,000 · Balance 80,000 F1: 2/48th of the shares subject to such option shall vest and become exercisable on March 1, 2026 and the remaining shares subject to the option shall vest in 46 substantially equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date. |
Filing footnotes · ownership attribution and instrument terms
F1: 2/48th of the shares subject to such option shall vest and become exercisable on March 1, 2026 and the remaining shares subject to the option shall vest in 46 substantially equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 06, 2026 Filed Feb 10, 2026 19:15 UTC | Septerna, Inc. SEPN · Entity 2452 | GrantStock Option (Right to Buy) · Derivative | 80,000 | $0.00 Strike: $25.41 | $0.00 |
DisclosureSEC source: 0001193125-26-045115 · ownership.xml · derivative · entry 1 Klein Uwe · CIK 0002040350 · SVP, Biological Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2036-02-05 F1 · derivative.exercise_date: 2/48th of the shares subject to such option shall vest and become exercisable on March 1, 2026 and the remaining shares subject to the option shall vest in 46 substantially equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date. Read SEC document |
| August 18, 2025 Filed Aug 19, 2025 17:02 UTC | Septerna, Inc. SEPN · Entity 2452 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,621 | $0.00 Strike: $6.81 | $0.00 |
DisclosureSEC source: 0000950170-25-110177 · ownership.xml · derivative · entry 7 Klein Uwe · CIK 0002040350 · SVP, Biological Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,027 Underlying: Common Stock · 7,621 shares Expires 2034-09-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 1/48th of the shares subject to such option shall vest and become exercisable in substantially equal monthly installments on each monthly anniversary of October 28, 2024, contingent upon the consummation of the Issuer's initial public offering, and subject to the Reporting Person's continuous service to the Issuer on each such date. Read SEC document |
| August 18, 2025 Filed Aug 19, 2025 17:02 UTC | Septerna, Inc. SEPN · Entity 2452 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,935 | $0.00 Strike: $2.76 | $0.00 |
DisclosureSEC source: 0000950170-25-110177 · ownership.xml · derivative · entry 6 Klein Uwe · CIK 0002040350 · SVP, Biological Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,001 Underlying: Common Stock · 4,935 shares Expires 2034-03-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/48th of the shares subject to such option shall vest and become exercisable in substantially equal monthly installments on each monthly anniversary of March 1, 2024, subject to the Reporting Person's continuous service to the Issuer on each such date. Read SEC document |
| August 18, 2025 Filed Aug 19, 2025 17:02 UTC | Septerna, Inc. SEPN · Entity 2452 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,452 | $0.00 Strike: $2.76 | $0.00 |
DisclosureSEC source: 0000950170-25-110177 · ownership.xml · derivative · entry 5 Klein Uwe · CIK 0002040350 · SVP, Biological Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,453 Underlying: Common Stock · 10,452 shares Expires 2033-11-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/48th of the shares subject to such option shall vest and become exercisable in substantially equal monthly installments on each monthly anniversary of August 1, 2023, subject to the Reporting Person's continuous service to the Issuer on each such date. Read SEC document |
| August 18, 2025 Filed Aug 19, 2025 17:02 UTC | Septerna, Inc. SEPN · Entity 2452 | Exercise / conversionCommon Stock | 7,621 | $6.81 | $51,899.01 |
DisclosureSEC source: 0000950170-25-110177 · ownership.xml · nonDerivative · entry 3 Klein Uwe · CIK 0002040350 · SVP, Biological Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,008 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 18, 2025 Filed Aug 19, 2025 17:02 UTC | Septerna, Inc. SEPN · Entity 2452 | Exercise / conversionCommon Stock | 4,935 | $2.76 | $13,620.60 |
DisclosureSEC source: 0000950170-25-110177 · ownership.xml · nonDerivative · entry 2 Klein Uwe · CIK 0002040350 · SVP, Biological Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,387 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 18, 2025 Filed Aug 19, 2025 17:02 UTC | Septerna, Inc. SEPN · Entity 2452 | Exercise / conversionCommon Stock | 10,452 | $2.76 | $28,847.52 |
DisclosureSEC source: 0000950170-25-110177 · ownership.xml · nonDerivative · entry 1 Klein Uwe · CIK 0002040350 · SVP, Biological Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,452 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2025 Filed Aug 11, 2025 19:01 UTC | Septerna, Inc. SEPN · Entity 2452 | GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $11.70 | $0.00 |
DisclosureSEC source: 0000950170-25-106790 · ownership.xml · derivative · entry 1 Klein Uwe · CIK 0002040350 · SVP, Biological Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2025-08-06 F1 · derivative.exercise_date: 1/48th of the shares subject to such option shall vest and become exercisable in substantially equal monthly installments on each monthly anniversary of August 1, 2025, subject to the Reporting Person's continuous service to the Issuer on each such date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.